Pneumonia Severity Index에 따른 원외획득폐렴 환자의 치료 현황 및 성과
Current Treatment and Clinical Outcomes of Community Acquired Pneumonia According to Pneumonia Severity Index
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There is considerable variability in rates of hospitalization for patients with community-acquired pneumonia (CAP) in part because of physicians’ uncertainty in assessing the severity of illness at presentation. The purpose of the study was to examine the current treatment patterns and factors influencing the Pneumonia Severity Index (PSI) and clinical outcomes in the patient with CAP. Method: The retrospective data collection of the patients with CAP was conducted and the data were reviewed. The collected data included demographic, clinical, laboratory and microbiological medical information. All patients were stratified into three risk groups according to PSI: low risk (PSI score I-II), moderate risk (III) and high risk (IV-V)groups. The examined treatment patterns were the appropriateness of admissions, category of antibiotics used. The prognostic factors associated with PSI and clinical outcomes were examined. Results: One hundred and six patients’ medical data were reviewed. The overall appropriateness of admissions was low presenting many of patients were admitted or intensely treated in the hospital despite of lower risk of prognosis and treated with intravenous antibiotics instead of oral fluoroquinolones. Primary pneumonia pathogens were Klebsiella pneumoniae (27%) and Streptococcus pneumoniae (21.6%). Mean LOS was 8.5 days and was significantly longer (10.0days) (p<0.001) in high risk group. The patients with age >65 (p<0.001), diabetes mellitus (p<0.001), mental alteration (p<0.001), and/or PaO₂<60 mmHg (p<0.001) had a tendency to have higher PSI. The prognostic factors associated with longer LOS were age >65 years (p=0.008), mental status alteration (p<0.001), dyspnea (p=0.002) and PSI score (p=0.001). The prognostic factors associated with mortality were congestive heart failure (p=0.038), systolic blood pressure <90 mmHg (p=0.002) and arterial pH <7.35 (p=0.013). Conclusion: Most of patients were found to over-utilize medical service according to appropriateness of admissions. The elderly, mentally altered patients with low PaO₂had higher PSI score with increased risk of LOS. The mortality could be increased in the patient with disease state of congestive heart failure, high blood pressure, and/or acidosis
Abstract
Purpose: There is considerable variability in rates of hospitalization for patients with community-acquired pneumonia (CAP) in part because of physicians’ uncertainty in assessing the severity of illness at presentation. The purpose of the study was to examine the current treatment patterns and factors influencing the Pneumonia Severity Index (PSI) and clinical outcomes in the patient with CAP. Method: The retrospective data collection of the patients with CAP was conducted and the data were reviewed. The collected data included demographic, clinical, laboratory and microbiological medical information. All patients were stratified into three risk groups according to PSI: low risk (PSI score I-II), moderate risk (III) and high risk (IV-V)groups. The examined treatment patterns were the appropriateness of admissions, category of antibiotics used. The prognostic factors associated with PSI and clinical outcomes were examined. Results: One hundred and six patients’ medical data were reviewed. The overall appropriateness of admissions was low presenting many of patients were admitted or intensely treated in the hospital despite of lower risk of prognosis and treated with intravenous antibiotics instead of oral fluoroquinolones. Primary pneumonia pathogens were Klebsiella pneumoniae (27%) and Streptococcus pneumoniae (21.6%). Mean LOS was 8.5 days and was significantly longer (10.0days) (p<0.001) in high risk group. The patients with age >65 (p<0.001), diabetes mellitus (p<0.001), mental alteration (p<0.001), and/or PaO₂<60 mmHg (p<0.001) had a tendency to have higher PSI. The prognostic factors associated with longer LOS were age >65 years (p=0.008), mental status alteration (p<0.001), dyspnea (p=0.002) and PSI score (p=0.001). The prognostic factors associated with mortality were congestive heart failure (p=0.038), systolic blood pressure <90 mmHg (p=0.002) and arterial pH <7.35 (p=0.013). Conclusion: Most of patients were found to over-utilize medical service according to appropriateness of admissions. The elderly, mentally altered patients with low PaO₂had higher PSI score with increased risk of LOS. The mortality could be increased in the patient with disease state of congestive heart failure, high blood pressure, and/or acidosis
참고문헌 (30)
- Liam CK, "Community-acquired pneumonia in patients requiring hospitalization", Respirology, 6, pp.259~264 (2001)
- American Thoracic Society, "Guidelines for the management of adults with community-acquired pneumonia", Am J Respir Crit Care Med, 163, pp.1730~1754 (2001)
- Carlos M, "Community -acquired pneumonia", Chest, 118, pp.1344~1354 (2000)
- Sopena N, "Prospective study of community-acquired pneumonia of bacterial etiology in adults", Eur J Clin M icrobiol Infect Dis, 18, pp.852~858 (1999)
- Friedrich, "Intrevenous", Oral sequential therapy in patients hospitalised with communityacquired pneumonia, 2002, pp.62, 303~317
- Bartlett JG, "Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America", Clin Infect Dis, 31, pp.347~382 (2000)
- Fine MJ, "A prediction rule to identify low-risk patients with community-acquired pneumonia", N Engl J Med, 336, pp.243~250 (1997)
- 유철웅, "노인환자에서의 원외폐렴", 대한 감염학회지, 32, pp.212~218 (2000)
- 정문현, "7개 대학 병원에서 조사한 지역 사회 폐렴의 원인균", 대한감염학회지, 29, pp.339~359 (1997)
- Fine MJ, "Processes and outcomes of care with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study", Arch Intern Med, 159, pp.970~980 (1999)
- Johnson PD, "3: Communityacquired pneumonia", Med J Aust, 176, pp.341~347 (2002)
- Cantrill SV, "Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department", Ann Emerg Med, 38, pp.107~113 (2001)
- Marrie TJ, "A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin", JAMA, 283, pp.749~755 (2000)
- 배중훈, "폐렴중증지수를 이용한 폐렴환자의 중증도 분류의 제안", 대한응급의학회지, 13(2), pp.129~134 (2002), 대한응급의학회
- Flanders WD, "Validation of the pneumonia severity index. Importance of studyspecific recalibration", Gen Intern Med, 14, pp.333~340 (1999)
- 윤지호, "목포지역에서의 지역사회 획득 폐렴의 임상적 연구", 결핵 및 호흡기질환, 51, pp.17~24 (2001)
- Ruiz M, "Diagnosis of pneumonia and monitoring of infection eradication", Drugs, 60, pp.1289~1302 (2000)
- Kaplan V, "Hospitalized communityacquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States", Am J Respir Crit Care Med, 165, pp.766~772 (2002)
- Stuble SP, "Community-acquired pneumonia--which patients are hospitalised", Swiss Med Wkly, 131, pp.188~192 (2001)
- Halm EA, "What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia", J Gen Intern Med, 16, pp.599~605 (2001)
- Fine MJ, "Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia", Am J Med, 109, pp.378~385 (2000)
- Ruiz M, "Severe communityacquired pneumonia. Risk factors and follow-up epidemiology", Am J Respir Crit Care Med, 160, pp.923~929 (1991)
- Hoe LK, "Hospitalized low-risk communityacquired pneumonia: Outcome and potential for costsavings", Respirology, 4, pp.307~309 (1999)
- Leroy O, "Simplified prediction rule for prognosis of patients with severe communityacquired pneumonia in ICUs", Chest, 116, pp.157~165 (1999)
- Lovering AM, "Epidemiology and resource utilization for patients hospitalized for lower respiratory tract infection", Clin Microbiol Infect, 7, pp.666~670 (2001)
- Lim WS, "Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines", Thorax, 56, pp.296~301 (2001)
- Marras TK, "Applying a prediction rule to identify low-risk patients with community-acquired pneumonia", Chest, 118, pp.1339~1343 (2000)
- Ruiz M, "Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity", Am J Respir Crit Care Med, 160, pp.397~405 (1999)
- Feagan BG, "Treatment and outcomes of community-acquired pneumonia at Canadian hospitals", CMAJ, 162, pp.1415~1420 (2000)
- Feldman C, "Prognostic factors in severe community-acquired pneumonia in patients without co-morbid illness", Respirology, 6, pp.323~330 (2001)